Nezam H. Afdhal, Chief Medical Officer at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 5,200 shares at $10.81 ($57K) on 2016-08-10, disclosed to the SEC on 2016-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.81 | 1,600 | $17K | 30.2% |
| 2 | $10.81 | 1,600 | $17K | 30.2% |
| 3 | $11.32 | 1,000 | $11K | 19.8% |
| 4 | $11.32 | 1,000 | $11K | 19.8% |
| Total | $11.01 avg | 5,200 | $57K | 100% |
| Filing → |
| SBPH | BUY | 2016-08-16 | $22K | — | Filing → |
| SBPH | BUY | 2016-08-15 | $29K | — | Filing → |